Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.
A NIBR postdoctoral fellowship leads to the discovery of a key genetic mutation behind a form of blindness.
Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.
A childhood fight for survival in Cambodia leads to a desire to help patients see better. Learn more about our ophthalmology researcher.
Novartis runs an annual program to support independent eye care initiatives worldwide via grant funding, including some in the world’s most remote areas and deprived communities.
Up the stairs to the entrance of the plane they climb: small children with cloudy eyes, teens with thick glasses and practiced squints, adults with dark shades.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.